Blog

Our perspective from the intersection of health, technology, and data.

Blog
  • Omnichannel
  • Oncology
  • Conferences
  • Media Tracking
  • Ferma.AI
  • Launch Excellence
  • HCP-PT
  • Talent Community
Celebrating International Women's Day 2021

Celebrating International Women's Day 2021

On International Women's Day, ZoomRxers #ChooseToChallenge any gender bias at the workplace. We commit to bringing about change and accelerating gender parity at the workplace.

  • Sai Keerthana
    Sai Keerthana
3 min read
Dermatologists and Rheumatologists Weigh In on Immunology Needs and Shifts in 2021
Research

Dermatologists and Rheumatologists Weigh In on Immunology Needs and Shifts in 2021

Across multiple indications, physicians anticipate 2021 will be an exciting year for advancing treatments across autoimmune and auto-inflammatory conditions. In a study conducted by ZoomRx late December 2020, 107 practicing U.S. rheumatologists

  • Ben Maimon
    Ben Maimon
  • Varsha Sundaram
    Varsha Sundaram
5 min read
Genome editing using CRISPR and gene therapy captured attention during this year’s fully virtual ASH annual meeting.
Conferences

Genome editing using CRISPR and gene therapy captured attention during this year’s fully virtual ASH annual meeting.

Early stage data showcasing the potential of both genome editing using CRISPR and gene therapy in non-malignant hematological disorders captured attention during this year’s fully virtual ASH annual meeting. A highlight of

  • Laurence Meloty-Kapella
    Laurence Meloty-Kapella
  • Surya Kani
    Surya Kani
5 min read
Consultant Andrew Yukawa on the Importance of Skill-Sharing and Team Outings

Consultant Andrew Yukawa on the Importance of Skill-Sharing and Team Outings

Andrew Yukawa is a Consultant in our San Francisco office. His willingness to both learn from his teammates and his generosity in sharing his own skills have made him a key member of

  • Aideen Murphy
    Aideen Murphy
3 min read
Q3 Earnings Calls Presented a Case for Cautious Optimism
Covid-19

Q3 Earnings Calls Presented a Case for Cautious Optimism

Having weathered many challenges in Q2 2020, biopharmaceutical firms, by and large, presented a case for optimism during Q3 2020 earnings calls. However, alongside this optimistic outlook were a number of voices expressing

  • Kat Lynch
    Kat Lynch
  • Monique J Menezes
    Monique J Menezes
  • Anu Mohan
    Anu Mohan
4 min read
Software Dev Lead Uma Sankar on Building to Uplift User Experience

Software Dev Lead Uma Sankar on Building to Uplift User Experience

Uma Sankar is a Software Development Lead in our Chennai office. She’s been at ZoomRx for over four years and has worked in software development for seven. Uma’s deep understanding of

  • Varsha Surendran
2 min read
ESMO 2020 delivered data representing major progress in oncology, as oncologists grow more accustomed to the virtual format
Conferences

ESMO 2020 delivered data representing major progress in oncology, as oncologists grow more accustomed to the virtual format

Oncologists are growing accustomed to attending the field’s major meetings virtually, with AACR, ASCO, and now ESMO 2020 having gone fully digital. While the virtual format has undoubtedly impacted attendees’ experiences and

  • Kinga Zapert
    Kinga Zapert
  • Aravind Nagarajan
    Aravind Nagarajan
  • Nithya Jyothi
    Nithya Jyothi
  • Varun Venkatesan
    Varun Venkatesan
5 min read
The Benefits of Video-Conferences over Phone Calls for Oncology Sales Interactions
Customer Engagement

The Benefits of Video-Conferences over Phone Calls for Oncology Sales Interactions

During the COVID-19 pandemic, video conferences have proven to drive much better results compared to phone calls for oncology sales interactions.

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Ty Harkness
    Ty Harkness
  • Vidhya Hariharan
    Vidhya Hariharan
3 min read
Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue
Oncology

Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue

The prostate-specific antigen (PSA) score has become a critical post-diagnosis tool for oncologists as they discuss prostate cancer disease state with their patients along with their families and caregivers. Oncologist-patient relationships are based

  • Vinny Valant
    Vinny Valant
  • Kinga Zapert
    Kinga Zapert
3 min read
Q2 Earnings Calls Provide Insight on the Future of In-Person Promotional Activity
Covid-19

Q2 Earnings Calls Provide Insight on the Future of In-Person Promotional Activity

A return to pre-pandemic levels of in-person promotional activity looks increasingly uncertain in H2 2020. Given this uncertainty, pharmaceutical manufacturers, from diversified, multinational firms to more focused, growth-stage companies are navigating the complexities

  • Kat Lynch
    Kat Lynch
  • Anu Mohan
    Anu Mohan
  • Monique J Menezes
    Monique J Menezes
3 min read
Exploring Factors Influencing Individualized Treatment: Breast Cancer
Customer Engagement

Exploring Factors Influencing Individualized Treatment: Breast Cancer

Oncologists often develop individualized treatment plans to ensure patients are receiving care tailored to their situation. Here are factors influencing their decisions.

  • Vinny Valant
    Vinny Valant
3 min read
Impact of COVID-19 on Therapeutic Approaches to Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Covid-19

Impact of COVID-19 on Therapeutic Approaches to Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Understand how neurology departments across the US and Canada are rapidly adapting their clinical care delivery systems to minimize risk of SARS-CoV-2 transmission.

  • Brittany Gazdag
    Brittany Gazdag
  • Aditya Ravi Kumar
    Aditya Ravi Kumar
4 min read
ASCO20 Delivered Practice-Changing Data in a Highly Accessible, Virtual Format; Despite Reduced Levels of Engagement among Oncologists
Conferences

ASCO20 Delivered Practice-Changing Data in a Highly Accessible, Virtual Format; Despite Reduced Levels of Engagement among Oncologists

Despite the disruption and transition to a completely virtual format, 2020 was not an off-year for ASCO. Nearly all oncologists who attended this year’s ASCO Annual Meeting felt that it represented at

  • Kinga Zapert
    Kinga Zapert
  • Melissa Green
    Melissa Green
  • Nathan DeCarolis
    Nathan DeCarolis
  • Vidhya Hariharan
    Vidhya Hariharan
  • Chloe Moss
    Chloe Moss
  • Carter Broad
    Carter Broad
  • Akshay Krishnan
5 min read
COVID-19: Physician Perspective on Efforts to Address Health Inequity
Covid-19

COVID-19: Physician Perspective on Efforts to Address Health Inequity

Evidence shows that the ongoing COVID-19 pandemic disproportionately impacts Black Americans. Here are some recommendations from physicians to advocate for heath equity.

  • Melissa Green
    Melissa Green
  • Andrew Yukawa
    Andrew Yukawa
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Subhadhra Padmanabhan Dhandapani
    Subhadhra Padmanabhan Dhandapani
4 min read
Meeting Physician Demand for High Quality Virtual Interactions
Customer Engagement

Meeting Physician Demand for High Quality Virtual Interactions

Pharmaceutical manufacturers and physicians have a mutual interest in virtual interactions, indicating a long-term shift in current models of engagement.

  • Ty Harkness
    Ty Harkness
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
3 min read
Q1 Earnings Calls Provide Insight into the Future of In-Person Promotional Activity
Covid-19

Q1 Earnings Calls Provide Insight into the Future of In-Person Promotional Activity

Pharmaceutical manufacturers, from diversified, multinational firms to focused, growth-stage companies are adapting to the reality of COVID-19. Recent Q1 investor calls provide insight into both the impact of the pandemic thus far on

  • Anu Mohan
    Anu Mohan
  • Kat Lynch
    Kat Lynch
3 min read
ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting
Conferences

ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting

With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and

  • Kinga Zapert
    Kinga Zapert
  • Melissa Green
    Melissa Green
  • Vidhya Hariharan
    Vidhya Hariharan
  • Nathan DeCarolis
    Nathan DeCarolis
4 min read
Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective
Covid-19

Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective

COVID-19 has served as a catalyst for the rapid uptake of telemedicine across a range of therapeutic categories. Initially, physicians adopted telemedicine, despite uncertainty surrounding reimbursement, in order to ensure the safety of

  • Kinga Zapert
    Kinga Zapert
  • Anu Mohan
    Anu Mohan
  • Sangeetha Govindarajan
    Sangeetha Govindarajan
  • Natielle Lohman
    Natielle Lohman
3 min read
A New Approach for Healthcare Dialogue Research
Customer Engagement

A New Approach for Healthcare Dialogue Research

Often, traditional research doesn't answer all questions pertaining to clinical treatment decisions. Here's ZoomRx's new approach to address such questions.

  • Vinny Valant
    Vinny Valant
2 min read
COVID-19 Impact on US Commercial Payers
Covid-19

COVID-19 Impact on US Commercial Payers

Throughout the COVID outbreak, health plans have collectively gone to great lengths to provide coverage in an urgent and unexpected situation. Plans have rapidly adapted to current healthcare needs...

  • Ben Druck
    Ben Druck
  • Andrew Yukawa
    Andrew Yukawa
  • Anirudh Vaidhyaa
    Anirudh Vaidhyaa
4 min read
How MDs are discussing migraine treatment options with patients
Customer Engagement

How MDs are discussing migraine treatment options with patients

Since 2018, the migraine treatment landscape has changed dramatically, with two new approvals in the month of February alone (Vyepti, Nurtec ODT). In light of these developments, we were curious about how migraine

  • Vinny Valant
    Vinny Valant
2 min read
COVID-19: Impact on Healthcare Practices and Treatment Decisions
Covid-19

COVID-19: Impact on Healthcare Practices and Treatment Decisions

The evolving COVID-19 pandemic is causing enormous impact on individuals and the healthcare system. Increasingly, it is also clear that COVID-19 has broad-ranging effects on our workplaces, our economy, and our social interactions.

  • Brittany Gazdag
    Brittany Gazdag
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Molly Osmulski
    Molly Osmulski
  • Hari Vignesh
    Hari Vignesh
3 min read
AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis
Conferences

AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis

As of March 13, the AAN annual meeting has been cancelled due to the ongoing global COVID-19 (Coronavirus) pandemic. We'll be keeping a close eye on any plans to hold events digitally and

  • Brittany Gazdag
    Brittany Gazdag
3 min read
Treating migraine was a major topic at AAPM 2020 - Here’s how migraine treaters perceive the anti-CGRPs
Conferences

Treating migraine was a major topic at AAPM 2020 - Here’s how migraine treaters perceive the anti-CGRPs

While opioid abuse deterrence and deprescribing topics were again center stage at the American Academy of Pain Medicine (AAPM) Annual Meeting this year—held February 26-March 1 in National Harbor, MD—headache and

  • Candy Lui
    Candy Lui
  • Molly Osmulski
    Molly Osmulski
  • Kannan Parthasarathy
    Kannan Parthasarathy
2 min read
Embracing Agility in Pharma Market Research
Customer Engagement

Embracing Agility in Pharma Market Research

The following is based on a presentation given by ZoomRx at the Pharma Market Research Conference in Newark, NJ on Feb 5-6, 2020. Please reach out via the form at the bottom of

  • Aravind Nagarajan
    Aravind Nagarajan
  • Candy Lui
    Candy Lui
3 min read

All rights reserved ZoomRx - 2020.   Privacy Policy


HOME
PERSPECTIVES
PANELISTS
CAREERS